Showing 5931-5940 of 20931 results for "".
- Bridging the Gap: Elevating Lipoprotein(a) Screening in Community Health Centershttps://reachmd.com/news/bridging-the-gap-elevating-lipoproteina-screening-in-community-health-centers/2475848/Elevated lipoprotein(a), a genetically inherited and independent risk factor for atherosclerotic cardiovascular disease, is frequently overlooked in routine screening protocols, especially within resource-challenged community health centers. Despite advances in recognizing traditiona
- Shifting Paradigms in Liver Disease Management: The Role of Advanced Therapies and Predictive Analyticshttps://reachmd.com/news/shifting-paradigms-in-liver-disease-management-the-role-of-advanced-therapies-and-predictive-analytics/2475851/Over the past two decades, the incidence of significant liver disease from heavy alcohol consumption has more than doubled, a change that demands urgent reconsideration of current hepatology practices. Clinicians are now witnessing a strain on liver care resources as the incidence of
- Anti-Reward Network: A New Frontier in Cocaine Addiction Treatmenthttps://reachmd.com/news/anti-reward-network-a-new-frontier-in-cocaine-addiction-treatment/2475840/Emerging evidence suggests that the 'anti-reward network', which is part of the brain system that counteracts reward and increases discomfort, plays a role in amplifying emotional pain during cocaine withdrawal. This understanding may unlock novel relapse prevention strategies for addiction speci
- 2025 EYE-CODE Protocol Update Published in Journal of Cosmetic Dermatologyhttps://reachmd.com/news/2025-eye-code-protocol-update-published-in-journal-of-cosmetic-dermatology/2475857/A newly published update to the EYE-CODE Protocol was recently published in the Journal of Cosmetic Dermatology, providing new insights and updates for nonopthalmologists. Accordin
- Bridging the Gap in Atopic Dermatitis Care for Skin of Colorhttps://reachmd.com/news/lebrikizumab-bridging-the-gap-in-atopic-dermatitis-care-for-skin-of-color/2475813/Atopic dermatitis in patients with darker phototypes often presents with intense inflammation and persistent pigmentary changes, yet clinical trials have historically underrepresented this population—recent findings position lebrikizumab as a potential solution to these gaps. Clinici
- Enhancing Lymph Node Staging in High-Risk Endometrial Cancer with FDG-PET/CThttps://reachmd.com/news/enhancing-lymph-node-staging-in-high-risk-endometrial-cancer-with-fdg-petct/2475815/Accurate lymph node staging in high-risk endometrial cancer directly influences prognosis and treatment pathways, yet CT and MRI often leave clinicians navigating blind spots. Precise delineation of nodal involvement shapes decisions on the extent of surgical staging and adjuvant the
- Decoding Myelin: The Role of TMEM63A Mutations in Neurological Disordershttps://reachmd.com/news/decoding-myelin-the-role-of-tmem63a-mutations-in-neurological-disorders/2475817/TMEM63A gene mutations are linked to undermining the structural integrity of myelin, potentially contributing to diagnostic challenges in patients with leukodystrophy and posing questions for
- Navigating the Gut Microbiota Dilemma in Modern Gastroenterologyhttps://reachmd.com/news/navigating-the-gut-microbiota-dilemma-in-modern-gastroenterology/2475836/Gastroenterologists increasingly confront the dilemma that even well-intentioned dietary restrictions can inadvertently erode gut microbiota diversity, challenging traditional approaches to nutritional management. As the gut microbiota emerges as a key determinant of gastrointestinal
- Unlocking Genetic Predictors of Multiple Sclerosis: Spotlight on rs361525 Polymorphismhttps://reachmd.com/news/unlocking-genetic-predictors-of-multiple-sclerosis-spotlight-on-rs361525-polymorphism/2475819/Despite extensive research into multiple sclerosis (MS), neurologists still face the urgent challenge of identifying which genetic variations most accurately predict disease risk, particularly focusing on the rs361525 promoter polymorphism to unlock more personalized treatment pathways.
- Cranial Ultrasound: The New Frontier in Neonatal Brain Assessmenthttps://reachmd.com/news/cranial-ultrasound-the-new-frontier-in-neonatal-brain-assessment/2475824/Amid the critical demands of neonatal intensive care, cranial ultrasound is emerging as the primary imaging modality for early, non-invasive assessment of brain health in preterm and term infants. Neonatologists and pediatric neurologists confront the necessity of effective, safe, an